<ARTICLE> 5 <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-31-2000 <PERIOD-END> SEP-30-2000 <CASH> 15,542 <SECURITIES> 61,319 <RECEIVABLES> 2,223 <ALLOWANCES> 139 <INVENTORY> 1,237 <CURRENT-ASSETS> 81,780 <PP&E> 4,202 <DEPRECIATION> 1,670 <TOTAL-ASSETS> 84,351 <CURRENT-LIABILITIES> 1,774 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 27 <OTHER-SE> 81,204 <TOTAL-LIABILITY-AND-EQUITY> 84,351 <SALES> 4,974 <TOTAL-REVENUES> 5,099 <CGS> 3,124 <TOTAL-COSTS> 3,124 <OTHER-EXPENSES> 6,025<F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (8,985) <INCOME-TAX> 0 <INCOME-CONTINUING> (8,985) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (8,985) <EPS-BASIC> (0.40) <EPS-DILUTED> (0.40) <FN> <F1>Items consist of research & development. </FN>